Bloomberg reports today that Johnson & Johnson intends to take its Linx reflux management system off the market outside the U ...

Johnson & Johnson, which said it made the decision based on a market assessment, did not specify the markets it is leaving or ...

Johnson & Johnson is withdrawing a device to treat debilitating acid reflux disease from markets outside the US, a move ...

Johnson & Johnson will halt international sales of its Linx reflux device, sparking concern among surgeons over limited options for GERD patients.

J&J: Johnson & Johnson announced the withdrawal of its LINX Reflux Management System in selected markets outside the U.S. due ...

Johnson & Johnson (JNJ) will withdraw its LINX Reflux Management System—a device used to treat acid reflux disease—from markets outside the U.S. from March, ...

The company has decided to withdraw the product, called LINX Reflux Management System, from March for commercial reasons, and ...

Johnson & Johnson (NYSE:JNJ) announced plans to remove its LINX Reflux Management System from markets outside the United ...

Johnson & Johnson is withdrawing the Linx Reflux Management System from markets outside the U.S., citing a commercial decision unrelated to the ...

Paula Gresty would gasp in pain as the terrible - and all-too-familiar - scorching sensation rose up into her throat at night ...

Experts reviewed the use of targeted therapy in cholangiocarcinoma, along with efforts to reduce the burden of ...

Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop® for the treatment of acid reflux, a treatment field ...